MetLife Investment Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.8M | Sell |
35,431
-2,785
| -7% | -$1.18M | 0.06% | 300 |
|
|
2026
Q1 | $18.1M | Sell |
38,216
-1,769
| -4% | -$891K | 0.09% | 195 |
|
|
2025
Q4 | $18.7M | Sell |
39,985
-2,486
| -6% | -$1.15M | 0.09% | 179 |
|
|
2025
Q3 | $18.1M | Sell |
42,471
-3,376
| -7% | -$1.31M | 0.09% | 197 |
|
|
2025
Q2 | $17.6M | Sell |
45,847
-2,682
| -6% | -$966K | 0.1% | 182 |
|
|
2025
Q1 | $16.8M | Sell |
48,529
-1,790
| -4% | -$576K | 0.09% | 194 |
|
|
2024
Q4 | $15.1M | Sell |
50,319
-152
| -0.3% | -$53.1K | 0.08% | 175 |
|
|
2024
Q3 | $20.5M | Sell |
50,471
-3,413
| -6% | -$1.25M | 0.12% | 137 |
|
|
2024
Q2 | $17.3M | Buy |
53,884
+5,788
| +12% | +$1.88M | 0.1% | 149 |
|
|
2024
Q1 | $16M | Sell |
48,096
-1,700
| -3% | -$519K | 0.11% | 147 |
|
|
2023
Q4 | $13.5M | Sell |
49,796
-1,816
| -4% | -$449K | 0.1% | 162 |
|
|
2023
Q3 | $12.7M | Sell |
51,612
-2,482
| -5% | -$679K | 0.1% | 159 |
|
|
2023
Q2 | $16.4M | Sell |
54,094
-1,233
| -2% | -$343K | 0.12% | 135 |
|
|
2023
Q1 | $14.6M | Sell |
55,327
-652
| -1% | -$166K | 0.1% | 142 |
|
|
2022
Q4 | $13.4M | Sell |
55,979
-1,796
| -3% | -$402K | 0.1% | 153 |
|
|
2022
Q3 | $10.6M | Sell |
57,775
-4,040
| -7% | -$805K | 0.09% | 181 |
|
|
2022
Q2 | $10.4M | Sell |
61,815
-14,412
| -19% | -$3.1M | 0.08% | 192 |
|
|
2022
Q1 | $19.1M | Buy |
76,227
+23,314
| +44% | +$5.85M | 0.12% | 129 |
|
|
2021
Q4 | $13.6M | Sell |
52,913
-2,764
| -5% | -$676K | 0.11% | 142 |
|
|
2021
Q3 | $13.5M | Sell |
55,677
-5,254
| -9% | -$1.28M | 0.12% | 138 |
|
|
2021
Q2 | $12.6M | Sell |
60,931
-2,250
| -4% | -$459K | 0.11% | 153 |
|
|
2021
Q1 | $11.9M | Sell |
63,181
-916
| -1% | -$162K | 0.11% | 156 |
|
|
2020
Q4 | $10.5M | Sell |
64,097
-2,754
| -4% | -$403K | 0.1% | 164 |
|
|
2020
Q3 | $8.33M | Sell |
66,851
-2,022
| -3% | -$250K | 0.09% | 183 |
|
|
2020
Q2 | $6.68M | Buy |
68,873
+680
| +1% | +$70.7K | 0.08% | 224 |
|
|
2020
Q1 | $6.13M | Sell |
68,193
-2,087
| -3% | -$270K | 0.08% | 198 |
|
|
2019
Q4 | $10.4M | Sell |
70,280
-2,099
| -3% | -$282K | 0.11% | 176 |
|
|
2019
Q3 | $8.72M | Sell |
72,379
-1,216
| -2% | -$157K | 0.1% | 196 |
|
|
2019
Q2 | $9.95M | Sell |
73,595
-2,326
| -3% | -$294K | 0.11% | 175 |
|
|
2019
Q1 | $9.9M | Sell |
75,921
-856
| -1% | -$115K | 0.11% | 174 |
|
|
2018
Q4 | $9.55M | Sell |
76,777
-1,753
| -2% | -$235K | 0.12% | 161 |
|
|
2018
Q3 | $10.9M | Sell |
78,530
-3,730
| -5% | -$464K | 0.11% | 162 |
|
|
2018
Q2 | $8.44M | Sell |
82,260
-1,980
| -2% | -$200K | 0.1% | 177 |
|
|
2018
Q1 | $8.17M | Sell |
84,240
-3,397
| -4% | -$330K | 0.1% | 193 |
|
|
2017
Q4 | $7.7M | Buy |
+87,637
| New | +$7.04M | 0.09% | 212 |
|
Other funds holding HCA
MetLife Investment Management's HCA Position: Q2 2026 in Review
MetLife Investment Management reduced its HCA Healthcare (HCA) stake by 7.3% in Q2 2026, selling an estimated $1.18M and leaving 35,431 shares worth $13.8M. The position accounts for 0.06% of the portfolio, ranked #300.
MetLife Investment Management first reported a position in HCA in Q4 2017 and has held it in 35 quarters since. The position peaked at $20.5M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- MetLife Investment Management held 35,431 shares of HCA Healthcare worth $13.8M as of Q2 2026.
- MetLife Investment Management sold 2,785 HCA Healthcare shares in Q2 2026, an estimated $1.18M.
- HCA Healthcare made up 0.06% of MetLife Investment Management's portfolio in Q2 2026, its #300 holding.
- MetLife Investment Management first reported a position in HCA Healthcare in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's HCA Healthcare position peaked at $20.5M in Q3 2024.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.